We’ve assembled the right team to do what others couldn’t bring a new class of targeted cancer therapies to patients by pairing strong science with focused execution.
Co-Founder & CEO
Ph.D., Co-Founder & VP Research
Ph.D., Head of Preclinical Development
Ph.D., CSO & Board Member
Ph.D., Co-Founder & Board Observer
MBA, Board Observer
MS, Board Observer